Limited Liability Company Agreements in the Biotechnology Industry

29 Contracts & Agreements

Browse by Company

ALNYLAM PHARMACEUTICALS, INC. (1 contract)
Athenex, Inc. (2)
BridgeBio Pharma, Inc. (2)
CANCER GENETICS, INC (1)
Capstone Therapeutics Corp. (1)
Cellectar Biosciences, Inc. (1)
Cullinan Oncology, LLC (1)
GENELUX CORP (1)
GENEREX BIOTECHNOLOGY CORP (1)
HedgePath Pharmaceuticals, Inc. (1)
Homology Medicines, Inc. (1)
iBio, Inc. (1)
INTREXON CORP (2)
Kadmon Holdings, Inc. (1)
Orgenesis Inc. (2)
PROGENITY, INC. (2)
Retrophin, Inc. (1)
RITTER PHARMACEUTICALS INC (1)
Spectrum Pharmaceuticals, Inc. (1)
Virios Therapeutics, LLC (1)
vTv Therapeutics Inc. (2)
Zentalis Pharmaceuticals, LLC (2)

Recent Contracts

Contingent Value Rights Agreement, dated October 7, 2024, by and between Virios Therapeutics, Inc and Broadridge Corporation Issuer Solutions, LLC a Pennsylvania limited liability... (Virios Therapeutics, LLC, Filed With SEC on November 8, 2024)
Amended and Restated Limited Liability Company Agreement of GondolaBio, LLC, dated as of August 16, 2024 (BridgeBio Pharma, Inc., Filed With SEC on August 21, 2024)
Amendment No. 1 to Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC (Orgenesis Inc., Filed With SEC on July 7, 2023)
Form of Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC (Orgenesis Inc., Filed With SEC on November 7, 2022)
Amended and Restated Limited Liability Company Agreement, by and between the registrant, TVAX Biomedical, Inc. and V2ACT Therapeutics, LLC, dated January 3, 2019 (GENELUX CORP, Filed With SEC on June 24, 2022)
Amended and Restated Limited Liability Company Agreement, dated March 10, 2022, by and among Oxford Biomedica Solutions LLC (f/k/a Roadrunner Solutions LLC), Homology Medicines,... (Homology Medicines, Inc., Filed With SEC on March 23, 2022)
Sublicense Agreement, dated February 16, 2012, by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation, Pharmacopeia, Inc., a Delaware limited liability company,... (Retrophin, Inc., Filed With SEC on February 24, 2022)
Third Amended and Restated Limited Liability Company Agreement, dated December 16, 2020, by and among Cullinan Oncology, LLC and its members (Cullinan Oncology, LLC, Filed With SEC on December 18, 2020)
Nominee Agreement, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company, Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability... (PROGENITY, INC., Filed With SEC on December 1, 2020)
Nominee Agreement, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company, Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability... (PROGENITY, INC., Filed With SEC on June 18, 2020)
Certificate of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation) (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
Plan of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation) (Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
Fourth Amended and Restated Limited Liability Company Agreement, dated November 20, 2018, by and among BridgeBio Pharma LLC and its members (BridgeBio Pharma, Inc., Filed With SEC on May 24, 2019)
LIMITED LIABILITY COMPANY AGREEMENT OF PETERSON ATHENEX PHARMACEUTICALS, LLC (Athenex, Inc., Filed With SEC on May 12, 2017)
ADDENDUM OF ADDITIONAL PRODUCT ADDED TO THE LIMITED LIABILITY COMPANY AGREEMENT OF PETERSON ATHENEX PHARMACEUTICALS, LLC DATED OCTOBER 4TH, 2016 November 29, 2016 (Athenex, Inc., Filed With SEC on May 12, 2017)
AMENDMENT NO. 1 TO Amendedand Restated Limited Liability Company Agreement Of iBioCMO LLC February 23, 2017 (iBio, Inc., Filed With SEC on February 24, 2017)
ACQUISITIONAGREEMENT AMONG GENEREXBIOTECHNOLGY CORPORATION., a Delaware corporation, HEMADIAGNOSTIC SYSTEMS, LLC, a Florida limited liability company AND STEPHENL BERKMAN Andthe... (GENEREX BIOTECHNOLOGY CORP, Filed With SEC on January 20, 2017)
PLAN OF CONVERSION Converting KADMON HOLDINGS, LLC (a Delaware limited liability company) into KADMON HOLDINGS, INC. (a Delaware corporation) (Kadmon Holdings, Inc., Filed With SEC on July 7, 2016)
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of VTV THERAPEUTICS LLC Dated as of July 29, 2015 (vTv Therapeutics Inc., Filed With SEC on August 4, 2015)
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT of VTV THERAPEUTICS LLC Dated as of [__________], 2015 (vTv Therapeutics Inc., Filed With SEC on July 23, 2015)
STATE OF DELAWARE CERTIFICATE OF CONVERSION FROM A DELAWARE LIMITED LIABILITY COMPANY TO A DELAWARE CORPORATION PURSUANT TO SECTION 265 OF THE DELAWARE GENERAL CORPORATE LAW (Capstone Therapeutics Corp., Filed With SEC on June 26, 2015)
OFFICELEASE Between DOUGLAS EMMETT 1997, LLC, a Delaware limited liability company as Landlord and RITTER PHARMACEUTICALS, INC., a Delaware corporation as Tenant Date June 25, 2013 (RITTER PHARMACEUTICALS INC, Filed With SEC on March 23, 2015)
Lease Agreement For 11500 S. Eastern Avenue, Suites 220, 240 & 270, Henderson, Nevada 89052 Between 11500 SouthEastern Avenue, LLC, a Nevada limited liability company Landlord and... (Spectrum Pharmaceuticals, Inc., Filed With SEC on August 8, 2014)
AMENDED ANDRESTATED LIMITED LIABILITY COMPANY AGREEMENT OF INTREXON ENERGYPARTNERS, LLC Dated as of March 26, 2014 (INTREXON CORP, Filed With SEC on April 4, 2014)
LIMITED LIABILITY COMPANY AGREEMENT OF S& I OPHTHALMIC, LLC (INTREXON CORP, Filed With SEC on October 30, 2013)
LIMITED LIABILITY COMPANY AGREEMENT OF ONCOSPIRE GENOMICS, LLC (CANCER GENETICS, INC, Filed With SEC on July 12, 2013)
COLLABORATIONAGREEMENT byand between NOVELOSTHERAPEUTICS, INC. (aDelaware corporation) and MUNDIPHARMAINTERNATIONAL CORPORATION LIMITED (aBermuda limited company) February11, 2009 (Cellectar Biosciences, Inc., Filed With SEC on March 30, 2009)
Ex-10.6 Limited Liability Company Agreement of Regulus Therapeutics LLC, dated as of September 6, 2007 (ALNYLAM PHARMACEUTICALS, INC., Filed With SEC on November 8, 2007)
AMENDED AND RESTATED STOCKPURCHASE AND SALE AGREEMENT by and among Tripos, Inc., a Utah corporation, Tripos UK Holdings Limited, a private limited company incorporated in England,... (HedgePath Pharmaceuticals, Inc., Filed With SEC on June 12, 2007)